1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Alembic Pharmaceuticals Limited
  6. News
  7. Summary
    APLLTD   INE901L01018

ALEMBIC PHARMACEUTICALS LIMITED

(APLLTD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Alembic Pharmaceuticals Gets US FDA Final Nod for Doxycycline Hyclate Tablets

01/04/2022 | 12:25am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ALEMBIC LIMITED 0.07% 68.3 End-of-day quote.-35.75%
ALEMBIC PHARMACEUTICALS LIMITED -0.32% 739.15 Delayed Quote.-7.53%
MAYNE PHARMA GROUP LIMITED 1.79% 0.285 Delayed Quote.-5.08%
All news about ALEMBIC PHARMACEUTICALS LIMITED
05/11Alembic Pharmaceuticals Gets US FDA Approval for COPD Symptoms Treatment
MT
05/11Alembic Pharmaceuticals Limited Announces USFDA Final Approval for Arformoterol Tartrat..
CI
05/04Alembic Pharmaceuticals Unit Gets US FDA's Approval for Blisters Cream; Shares Slide 7%
MT
05/03Alembic Pharmaceuticals Sees Sharp Drop in Fiscal Q4 Consolidated Net Profit
MT
05/02TRANSCRIPT : Alembic Pharmaceuticals Limited, Q4 2022 Earnings Call, May 02, 2022
CI
05/02Alembic Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March ..
CI
05/02Alembic Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended M..
CI
05/02Alembic Pharmaceuticals Limited Recommends Dividend for the Financial Year 2021-22
CI
04/25Alembic Pharmaceuticals Gets US FDA Nod for Clobetasol Propionate Foam
MT
04/20Alembic Pharmaceuticals Gets US FDA's Tentative Approval for Stable Symptomatic Heart F..
MT
More news
Financials
Sales 2022 51 746 M 665 M 665 M
Net income 2022 6 836 M 87,8 M 87,8 M
Net Debt 2022 4 273 M 54,9 M 54,9 M
P/E ratio 2022 21,3x
Yield 2022 1,11%
Capitalization 145 B 1 876 M 1 866 M
EV / Sales 2022 2,89x
EV / Sales 2023 2,59x
Nbr of Employees 12 160
Free-Float 29,7%
Chart ALEMBIC PHARMACEUTICALS LIMITED
Duration : Period :
Alembic Pharmaceuticals Limited Technical Analysis Chart | APLLTD | INE901L01018 | MarketScreener
Technical analysis trends ALEMBIC PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 739,15 INR
Average target price 810,75 INR
Spread / Average Target 9,69%
EPS Revisions
Managers and Directors
Chirayu Ramanbhai Amin Executive Chairman & Chief Executive Officer
Raj Kumar Shriram Baheti CFO, Finance Director & Executive Director
Jitendra Mishra Chief Information Officer & Vice President
Charandeep Singh Saluja Secretary & Compliance Officer
Pranav Natverlal Parikh Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ALEMBIC PHARMACEUTICALS LIMITED-7.53%1 882
JOHNSON & JOHNSON3.38%465 363
PFIZER, INC.-15.46%280 096
ABBVIE INC.13.37%271 251
ELI LILLY AND COMPANY5.58%262 514
ROCHE HOLDING AG-15.85%258 421